RU98100200A - HELICOBACTER PYLORI ANTIGENS AND VACCINE COMPOSITIONS - Google Patents

HELICOBACTER PYLORI ANTIGENS AND VACCINE COMPOSITIONS

Info

Publication number
RU98100200A
RU98100200A RU98100200/13A RU98100200A RU98100200A RU 98100200 A RU98100200 A RU 98100200A RU 98100200/13 A RU98100200/13 A RU 98100200/13A RU 98100200 A RU98100200 A RU 98100200A RU 98100200 A RU98100200 A RU 98100200A
Authority
RU
Russia
Prior art keywords
helicobacter pylori
vaccine compositions
pylori antigens
antigens
vaccine
Prior art date
Application number
RU98100200/13A
Other languages
Russian (ru)
Other versions
RU2195463C2 (en
Inventor
Ингрид Белин
Анн-Мари Свеннерхольм
Original Assignee
Астра Актиеболаг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9502007A external-priority patent/SE9502007D0/en
Priority claimed from SE9601085A external-priority patent/SE9601085D0/en
Application filed by Астра Актиеболаг filed Critical Астра Актиеболаг
Publication of RU98100200A publication Critical patent/RU98100200A/en
Application granted granted Critical
Publication of RU2195463C2 publication Critical patent/RU2195463C2/en

Links

Images

Claims (1)

Текст формулы заявки в факсимильном виде (см. чертежи)The text of the application formula in facsimile form (see drawings)
RU98100200/13A 1995-06-01 1996-06-03 Antigen of helicobacter pylori and vaccine composition RU2195463C2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
SE9502007-9 1995-06-01
SE9502007A SE9502007D0 (en) 1995-06-01 1995-06-01 Novel polypeptides
SE9601085-5 1996-03-21
SE9601085A SE9601085D0 (en) 1996-03-21 1996-03-21 Novel polypeptides

Publications (2)

Publication Number Publication Date
RU98100200A true RU98100200A (en) 1999-10-20
RU2195463C2 RU2195463C2 (en) 2002-12-27

Family

ID=26662316

Family Applications (1)

Application Number Title Priority Date Filing Date
RU98100200/13A RU2195463C2 (en) 1995-06-01 1996-06-03 Antigen of helicobacter pylori and vaccine composition

Country Status (22)

Country Link
US (2) US6025164A (en)
EP (1) EP0828757A1 (en)
JP (1) JP3380559B2 (en)
KR (1) KR19990022131A (en)
CN (1) CN1191544A (en)
AR (1) AR003125A1 (en)
BR (1) BR9608627A (en)
CA (1) CA2222797A1 (en)
CZ (1) CZ357397A3 (en)
EE (1) EE9700306A (en)
HU (1) HUP9901546A3 (en)
IL (1) IL122340A0 (en)
IS (1) IS4615A (en)
MY (1) MY119003A (en)
NO (1) NO975490L (en)
NZ (1) NZ303356A (en)
PL (1) PL323741A1 (en)
RU (1) RU2195463C2 (en)
SK (1) SK155297A3 (en)
TR (1) TR199701471T1 (en)
TW (1) TW570925B (en)
WO (1) WO1996038475A1 (en)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2682122B1 (en) * 1991-10-03 1995-06-09 Pasteur Institut NEW GENES OF HELICOBACTER PYLORI. THEIR USE FOR THE PREPARATION OF RECOMBINANT STRAINS OF H. PYLORI.
US5843460A (en) * 1993-05-19 1998-12-01 Institut Pasteur Immunogenic compositions against helicobacter infection, polypeptides for use in the compositions, and nucleic acid sequences encoding said polypeptides
JPH08509873A (en) 1993-05-19 1996-10-22 アンスティテュ・パストゥール Immune composition against Helicobacter infection, polypeptide used in the composition and nucleic acid sequence encoding the polypeptide
US5871749A (en) * 1993-07-27 1999-02-16 Csl Limited Therapeutic treatment of H. pylori associated gastroduodenal disease
US6406703B1 (en) 1993-07-27 2002-06-18 Csl Limited Treatment of H. pylori associated gastroduodenal disease
AUPM612494A0 (en) * 1994-06-08 1994-06-30 Csl Limited Treatment or prevention of helicobacter infection
KR19990022600A (en) * 1995-06-07 1999-03-25 클래스 빌헬름슨 Helicobacter pyrroli related nucleic acid and amino acid sequences for diagnosis and treatment
JP2001520671A (en) * 1997-03-26 2001-10-30 アバント インミューノセラピューティクス，インコーポレイテッド Carbohydrate antigen immunoreacts with polyclonal antiserum against Helicobacter pylori
BR9809426A (en) * 1997-04-30 2000-06-13 Merieux Oravax Composition of anti-helicobacter vaccine for use by the subdiaphragmatic systemic route and combined mucosal / parenteral immunization method
SE9702241D0 (en) * 1997-06-12 1997-06-12 Astra Ab Vaccine compositions IV
SE9702242D0 (en) * 1997-06-12 1997-06-12 Astra Ab Vaccine compositions V
US7393529B2 (en) * 1998-04-09 2008-07-01 Idexx Laboratories, Inc. Methods and compositions for inhibiting binding of IgE to a high affinity receptor
SE9801288D0 (en) * 1998-04-14 1998-04-14 Astra Ab Vaccine delivery system and method of production
DE69922364T2 (en) * 1998-04-30 2005-11-03 Chiron S.R.L. Method of immunization against and treatment of H. pylori infections
AU3205000A (en) * 1999-02-19 2000-09-04 Astrazeneca Ab Expression of helicobacter polypeptides in pichia pastoris
GB9924351D0 (en) 1999-10-14 1999-12-15 Brennan Frank Immunomodulation methods and compositions
WO2001083531A1 (en) * 2000-04-27 2001-11-08 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Method for identifying helicobacter antigens
GB0010371D0 (en) * 2000-04-29 2000-06-14 Astrazeneca Ab Helicobacter pylori antigens
US20020107368A1 (en) * 2000-12-07 2002-08-08 Jing-Hui Tian Helicobacter proteins, gene sequences and uses thereof
AU2004266213A1 (en) 2003-08-15 2005-03-03 University Of Florida Identification of porphyromonas gingivalis virulence polynucleotides for diagnosis, treatment, and monitoring of periodontal diseases
US7381547B2 (en) * 2004-04-28 2008-06-03 Tzam Diagnostics, Llc Methods and compositions to detect bacteria using multiplex PCR
KR100613924B1 (en) * 2004-06-23 2006-08-21 현대자동차주식회사 Automobile fuel system
WO2007014179A2 (en) * 2005-07-25 2007-02-01 University Of Rochester Method for controlling immunodominance
CA2685308A1 (en) * 2007-04-27 2009-01-29 Dow Global Technologies Inc. Improved production and in vivo assembly of soluble recombinant icosahedral virus-like particles
CN101496898B (en) * 2009-02-16 2011-06-15 中国人民解放军军事医学科学院生物工程研究所 Vaccine for preventing and/or treating Helicobacter pylori infection
RU2449805C1 (en) 2011-01-27 2012-05-10 Общество С Ограниченной Ответственностью "Гармония" Peptide pharmaceutical composition, based drug for gastroduodenal diseases caused by helicobacter pylori, and method of using it
BR112018012033A2 (en) 2015-12-14 2018-12-04 Max Planck Gesellschaft immunogenic composition and method for detecting h infection. pylori in a subject
US10577409B2 (en) * 2016-05-26 2020-03-03 Sagabio Co., Ltd. Monoclonal antibody inhibiting immunosuppressive functions of pathogens, antigen-binding fragment thereof, and hybridomas producing such antibody
CN107456578A (en) * 2016-06-03 2017-12-12 硕英生医股份有限公司 A kind of method of immune suppression function for closing pathogen and application thereof
EP3272354A1 (en) 2016-07-20 2018-01-24 Technische Universität München Agents and methods for the prevention or treatment of h. pylori infections
CN111467368B (en) * 2020-04-13 2021-05-28 江南大学 Application of oligosaccharide compound containing heptasaccharide chain in preparation of helicobacter pylori vaccine
CN113144182B (en) * 2021-04-22 2023-03-10 成都欧林生物科技股份有限公司 Helicobacter pylori oral sustained-release vaccine and preparation and application thereof
CN113896775A (en) * 2021-08-25 2022-01-07 河北医科大学第四医院 Specific immunogenic peptide fragment of helicobacter pylori

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69033600T2 (en) * 1989-03-09 2001-04-05 American Cyanamid Co Process for the isolation of Haemopnilus influenzae Protein-E
US5721349A (en) * 1992-02-26 1998-02-24 Vanderbilt University Vacuolating toxin-deficient H. pylori
MX9301706A (en) * 1992-04-13 1994-05-31 Oravax Inc VACCINE COMPOSITION FOR THE TREATMENT OF HELICOBACTER INFECTION.
US5420014A (en) * 1992-04-30 1995-05-30 Auspharm International Ltd. Rapid in vitro test for helicobacter pylori using saliva

Similar Documents

Publication Publication Date Title
RU98100200A (en) HELICOBACTER PYLORI ANTIGENS AND VACCINE COMPOSITIONS
NO975490D0 (en) Heliobacter pylori antigens and vaccine compositions
FI972945A (en) Compositions suitable for the administration of antigens
FR2660341B1 (en) COMPLEX PHONIC INSULATION MATERIAL AND FLOOR USING THE SAME.
TR199501650A2 (en) Mouth compositions.
NO993694L (en) Sylphonylurea and adjuvant based solid compositions
TR199501645A2 (en) Mouth compositions.
DK0687728T3 (en) Reovirus strain 2177 and vaccine containing the same
TR199501651A2 (en) Mouth compositions.
RU97116840A (en) ANXIETY VACCINES
EE9900566A (en) Vaccine compositions containing Helicobacter pylori FlgE polypeptide
RU99111594A (en) HELICOBACTER PYLORI NUCLEIC ACID AND AMINO ACID SEQUENCES AND THEIR VACCINE COMPOSITIONS
DE68908394T2 (en) Unsymmetrical squarain compositions and imaging elements using such compositions.
TH25451S (en) Seashell shape jewelry packaging box
TH12454S1 (en) Enamel color sample device
TH10583EX (en) Toothbrush hair placement
RU98115572A (en) CONFORMATION-LIMITED AROMATIC PROTEIN INHIBITORS OF MICROSOMIC TRIGLICERIDE TRANSFER AND METHODS OF APPLICATION
TH47450EX (en) Air cleaner
TH37927EX (en) Insect trap
TH9137S1 (en) Towel rail
TH26653S (en) Towel rail
TH24981S (en) Fax machine
TH1207S1 (en) Container with lid
TH4374S (en) Container with lid
TH6867S1 (en) CD envelope